Flax Canada 2015 Inc. Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2007
NCT00927199
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now